783 related articles for article (PubMed ID: 19329230)
1. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].
Angel Díaz M; Ramón Hernández J; Martínez-Martínez L; Rodríguez-Baño J; Pascual A;
Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):503-10. PubMed ID: 19329230
[TBL] [Abstract][Full Text] [Related]
2. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)].
Hernández JR; Pascual A; Cantón R; Martínez-Martínez L;
Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):77-82. PubMed ID: 12586030
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
4. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
Xiong Z; Zhu D; Zhang Y; Wang F
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
[TBL] [Abstract][Full Text] [Related]
5. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
[TBL] [Abstract][Full Text] [Related]
6. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
Basak S; Mallick SK; Bose S
J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
[TBL] [Abstract][Full Text] [Related]
7. Hospital cross-transmission of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.
Cholley P; Thouverez M; Gbaguidi-Haore H; Sauget M; Slekovec C; Bertrand X; Talon D; Hocquet D
Med Mal Infect; 2013 Aug; 43(8):331-6. PubMed ID: 23876202
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.
Liao CH; Sheng WH; Wang JT; Sun HY; Wang HK; Hsueh PR; Chen YC; Chang SC
J Microbiol Immunol Infect; 2006 Feb; 39(1):59-66. PubMed ID: 16440125
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors.
Ozgunes I; Erben N; Kiremitci A; Kartal ED; Durmaz G; Colak H; Usluer G; Colak E
Saudi Med J; 2006 May; 27(5):608-12. PubMed ID: 16680246
[TBL] [Abstract][Full Text] [Related]
11. [Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].
González Mesa L; Ramos Morí A; Nadal Becerra L; Morffi Figueroa J; Hernández Robledo E; Alvarez AB; Marchena Bequer JJ; González Alemán M; Villain Plous C
Rev Cubana Med Trop; 2007; 59(1):52-8. PubMed ID: 23427419
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
Koksal F; Ak K; Kucukbasmaci O; Samasti M
Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
[TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
Lautenbach E; Patel JB; Bilker WB; Edelstein PH; Fishman NO
Clin Infect Dis; 2001 Apr; 32(8):1162-71. PubMed ID: 11283805
[TBL] [Abstract][Full Text] [Related]
14. Low frequency of antibiotic resistance among urine isolates of Escherichia coli in the community, despite a major hospital outbreak with Klebsiella pneumoniae producing CTX-M-15 in Uppsala County.
Lindbäck H; Lindbäck J; Sylvan S; Melhus A
Scand J Infect Dis; 2010 Apr; 42(4):243-8. PubMed ID: 20085420
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
[TBL] [Abstract][Full Text] [Related]
16. [Recent evolution and characterization of extended-spectrum beta-lactamase producing enterobacteria in the CHU of Nice (2005-2007)].
Giraud-Morin C; Fosse T
Pathol Biol (Paris); 2008; 56(7-8):417-23. PubMed ID: 18848404
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
Severin JA; Mertaniasih NM; Kuntaman K; Lestari ES; Purwanta M; Lemmens-Den Toom N; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
J Antimicrob Chemother; 2010 Mar; 65(3):465-9. PubMed ID: 20053690
[TBL] [Abstract][Full Text] [Related]
19. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
Shanthi M; Sekar U
J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand.
Heffernan HM; Woodhouse RE; Pope CE; Blackmore TK
Int J Antimicrob Agents; 2009 Dec; 34(6):544-9. PubMed ID: 19748232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]